Entero Therapeutics, Inc. (GRDX) — DEF 14A Filings
All DEF 14A filings from Entero Therapeutics, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Entero Therapeutics Sets Virtual Annual Meeting for June 30
— Jun 4, 2025 Risk: low
Entero Therapeutics, Inc. (GRDX) filed a Definitive Proxy Statement (DEF 14A) on June 4, 2025, for its upcoming virtual Annual Meeting of Stockholders on June 3
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX